Guangdong Lifestrong Pharmacy Co., Ltd. (301111.SZ)
301111.SZ Stock Price Chart
Explore Guangdong Lifestrong Pharmacy Co., Ltd. interactive price chart. Choose custom timeframes to analyze 301111.SZ price movements and trends.
301111.SZ Company Profile
Discover essential business fundamentals and corporate details for Guangdong Lifestrong Pharmacy Co., Ltd. (301111.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
7 Dec 2021
Employees
667.00
Website
https://www.wnqzy.com.cnCEO
Ou Xiantao
Description
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. The company produces tablets, pills, injection, mixture, granules, and other related products. It offers respiratory, pediatric, gynecology, urinary, and nutrition and healthcare category products. The company was founded in 1951 and is based in Shantou, China.
301111.SZ Financial Timeline
Browse a chronological timeline of Guangdong Lifestrong Pharmacy Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 27 May 2025
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 27 May 2025.
Dividend declared on 23 May 2024
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 23 May 2024.
Dividend declared on 1 Jun 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 1 Jun 2023.
Dividend declared on 26 May 2022
A dividend of ¥0.16 per share was announced, adjusted to ¥0.16. The dividend was paid on 26 May 2022.
301111.SZ Stock Performance
Access detailed 301111.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.